Insider Trading Activity Magellan Health, Inc. (NASDAQ:MGLN) – General Counsel Sold 4,559 shares of Stock

ME Staff
-
0

Insider Trading Activity For Magellan Health, Inc. (NASDAQ:MGLN)

Daniel N Gregoire , General Counsel of Magellan Health, Inc. (NASDAQ:MGLN) reportedly Sold 4,559 shares of the company’s stock at an average price of 80.68 for a total transaction amount of $367,820.12 SEC Form

Insider Trading History For Magellan Health, Inc. (NASDAQ:MGLN)

  • On 10/3/2012 Tina Blasi, CEO, sold 1,955 with an average share price of $52.03 per share and the total transaction amounting to $101,718.65.View SEC Filing
  • On 10/5/2012 Tina Blasi, CEO, sold 3,000 with an average share price of $52.06 per share and the total transaction amounting to $156,180.00.View SEC Filing
  • On 5/31/2013 Clapper Caskie Lewis, Insider, sold 14,002 with an average share price of $55.00 per share and the total transaction amounting to $770,110.00.View SEC Filing
  • On 6/3/2013 Clapper Caskie Lewis, Insider, sold 43,399 with an average share price of $55.00 per share and the total transaction amounting to $2,386,945.00.View SEC Filing
  • On 6/19/2013 Jonathan N Rubin, CFO, sold 1,600 with an average share price of $57.06 per share and the total transaction amounting to $91,296.00.View SEC Filing
  • On 7/8/2013 Jonathan N Rubin, CFO, sold 6,150 with an average share price of $57.05 per share and the total transaction amounting to $350,857.50.View SEC Filing
  • On 7/9/2013 Jonathan N Rubin, CFO, sold 27,950 with an average share price of $57.92 per share and the total transaction amounting to $1,618,864.00.View SEC Filing

    • Analyst Ratings For Magellan Health, Inc. (NASDAQ:MGLN)
    These are 1 Sell Rating, 3 Buy Ratings .
    The current consensus rating for Magellan Health, Inc. (NASDAQ:MGLN) is Buy (Score: 2.50) with a consensus target price of $80.25 , a potential (1.39% upside)

    Analyst Ratings History For Magellan Health, Inc. (NASDAQ:MGLN)

    • On 11/23/2016 Barclays PLC Boost Price Target of rating Underweight with a price target of $61.00 to $69.00
    • On 2/24/2017 Jefferies Group LLC Lower Price Target of rating Buy with a price target of $89.00 to $88.00
    • On 6/25/2017 Leerink Swann Reiterated Rating Outperform with a price target of $68.00 to $73.00
    • On 7/13/2017 KeyCorp Upgraded rating Sector Weight to Overweight with a price target of $91.00

    Recent Trading Activity for Magellan Health, Inc. (NASDAQ:MGLN)
    Shares of Magellan Health, Inc. closed the previous trading session at 79.15 down -2.10 -2.58% with 252,180 shares trading hands.